Protagonist Therapeutics
PTGX
#2241
Rank
C$11.89 B
Marketcap
C$182.22
Share price
2.00%
Change (1 day)
54.39%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2026 (TTM): C$1.78

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is C$1.75. In 2025 the company made an earnings per share (EPS) of C-$2.94 a decrease over its 2024 EPS that were of C$6.42.

EPS history for Protagonist Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.78-160.73%
2025C-$2.94-145.76%
2024C$6.42-402.7%
2023C-$2.12-43.08%
2022C-$3.73-3.7%
2021C-$3.8735%
2020C-$2.87-33.33%
2019C-$4.3074.42%
2018C-$2.46-20.74%
2017C-$3.11-45.64%
2016C-$5.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.93-210.66%๐Ÿ‡บ๐Ÿ‡ธ USA